ME00030B - GABOKSADOL ZA LEČENJE DEPRESIJE l DRUGIH AFEKTIVNIH POREMEĆAJA - Google Patents

GABOKSADOL ZA LEČENJE DEPRESIJE l DRUGIH AFEKTIVNIH POREMEĆAJA

Info

Publication number
ME00030B
ME00030B MEP-2008-19A MEP200819A ME00030B ME 00030 B ME00030 B ME 00030B ME P200819 A MEP200819 A ME P200819A ME 00030 B ME00030 B ME 00030B
Authority
ME
Montenegro
Prior art keywords
gaboxadol
affective disorders
treating depression
preparation
pharmaceutical composition
Prior art date
Application number
MEP-2008-19A
Other languages
English (en)
French (fr)
Unknown language (me)
Inventor
Connie Sanchez
Bjarke Ebert
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=58707228&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME00030(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H Lundbeck As filed Critical H Lundbeck As
Priority claimed from PCT/DK2004/000459 external-priority patent/WO2004112786A2/en
Publication of ME00030B publication Critical patent/ME00030B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MEP-2008-19A 2003-06-25 2004-06-25 GABOKSADOL ZA LEČENJE DEPRESIJE l DRUGIH AFEKTIVNIH POREMEĆAJA ME00030B (me)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US48301903P 2003-06-25 2003-06-25
DKPA200300956 2003-06-25
US53512304P 2004-01-07 2004-01-07
DKPA200400016 2004-01-07
PCT/DK2004/000459 WO2004112786A2 (en) 2003-06-25 2004-06-25 Gaboxadol for treating depression and other affective disorders

Publications (1)

Publication Number Publication Date
ME00030B true ME00030B (me) 2010-06-10

Family

ID=58707228

Family Applications (2)

Application Number Title Priority Date Filing Date
MEP-19/08A MEP1908A (xx) 2003-06-25 2004-06-25 Gabaksadol za liječenje depresije i drugih afektivnih poremećaja
MEP-2008-19A ME00030B (me) 2003-06-25 2004-06-25 GABOKSADOL ZA LEČENJE DEPRESIJE l DRUGIH AFEKTIVNIH POREMEĆAJA

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MEP-19/08A MEP1908A (xx) 2003-06-25 2004-06-25 Gabaksadol za liječenje depresije i drugih afektivnih poremećaja

Country Status (10)

Country Link
KR (1) KR20060025192A (no)
AR (1) AR047550A1 (no)
CA (2) CA2529805A1 (no)
CL (2) CL2004001607A1 (no)
EA (1) EA200600101A1 (no)
IS (1) IS8138A (no)
ME (2) MEP1908A (no)
NO (1) NO20060229L (no)
RS (1) RS20050911A (no)
TW (1) TW200509918A (no)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11123332B2 (en) 2018-11-21 2021-09-21 Certego Therapeutics Inc. Gaboxadol for reducing risk of suicide and rapid relief of depression
US11597726B2 (en) 2020-05-20 2023-03-07 Certego Therapeutics Inc. Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11123332B2 (en) 2018-11-21 2021-09-21 Certego Therapeutics Inc. Gaboxadol for reducing risk of suicide and rapid relief of depression
US11597726B2 (en) 2020-05-20 2023-03-07 Certego Therapeutics Inc. Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders

Also Published As

Publication number Publication date
AR047550A1 (es) 2006-01-25
CL2010000166A1 (es) 2010-07-02
MEP1908A (xx) 2010-02-10
EA200600101A1 (ru) 2006-06-30
CA2529805A1 (en) 2004-12-29
CA2692334A1 (en) 2004-12-29
RS20050911A (en) 2007-08-03
NO20060229L (no) 2006-01-16
KR20060025192A (ko) 2006-03-20
IS8138A (is) 2005-11-21
CL2004001607A1 (es) 2005-05-27
TW200509918A (en) 2005-03-16

Similar Documents

Publication Publication Date Title
CY1120961T1 (el) Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
CY1110046T1 (el) Γαβοξαδολη για τη θεραπεια της καταθλιψης και αλλων συναισθηματικων διαταραχων
PA8596901A1 (es) Inhibidores de p38 y metodos de uso de ellos
DK1556021T3 (da) Farmaceutiske sammensætninger omfattende flavonoider og menthol samt fremgangsmåder til behandling med brug af nævnte sammensætninger
DE60117605D1 (de) Thiazolyl-inhibitoren von tyrosinkinasen der tec-familie
EA200601553A1 (ru) Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
ATE554114T1 (de) Copolymer mit zwitterionischen einheiten und anderen einheiten, das copolymer umfassende zusammensetzung und verwendung
MEP6208A (en) The combination of a serotonin reuptake inhibitor and a 5-ht¿2c? antagonist, inverse agonist or partial agonist
BR0304648A (pt) Combinação de inibidores de ciclooxigenase-2 e talidomida para o tratamento de neoplasia
EA200701820A1 (ru) Применение диосметиновых соединений при лечении и профилактике тромботических патологий
BRPI0412265A (pt) uso de calcitonina em osteoartrite
ATE409065T1 (de) Inhibitoren der 17 beta- hydroxysteroiddehydrogenase des typs 3 zur behandlung androgenabhängiger krankheiten
NO20065859L (no) Bruk av IL-17 behandlingen av fertilitetsrelaterte lidelser
NO20093542L (no) Inhibering av tumormetastase ved hjelp av anti-neuropilin 2-antistoffer
DE602005009681D1 (de) Haarbehandlungszusammensetzungen mit einem disaccharid; einer disäure und einer ammoniumionen-quelle
HRP20050579B1 (hr) Nove sinergistiäśne kombinacije koje sadrže roflumilast i formoterol
RS54185B1 (en) USE OF 24-ORDER
DK1575590T3 (da) Carbostyrilderivater og serotoningenoptagelsesinhibitorer til behandling af sindsstemningslidelser
CL2008003602A1 (es) Compuestos derivados de triazolotriazinas y triazolopirazinas sustituidas; composicion farmaceutica; y su uso en el tratamiento y/o profilaxis de trastornos hematologicos.
ATE506954T1 (de) Adjuvans mit einem oligonukleotid und nicht- toxischem lps
AR039664A1 (es) Composicion farmaceutica que comprende un inhibidor de lipasa y glucomanan
RS51534B (en) NEW COMPOUND OF SINUSOID IF CURRENT INHIBITORS AND CALCIUM INHIBITOR AND PHARMACEUTICAL MIXTURE CONTAINED BY IT
ME00030B (me) GABOKSADOL ZA LEČENJE DEPRESIJE l DRUGIH AFEKTIVNIH POREMEĆAJA
BRPI0418749A (pt) composição herbal
ATE536874T1 (de) Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen